UNIVERSITY OF SOUTH FLORIDA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1956-01-01

Employees: 10K

Market Cap: -

Website: http://www.usf.edu

Clinical Trials

Oxymetazoline Hydrochloride in Combination With Nasal Glucocorticosteroid for Perennial Allergic and Non-allergic Rhinitis in Subjects With Persistent Nasal Congestion

Not Applicable

Terminated

Conditions: Chronic Rhinitis

Interventions: Drug: Oxymetazoline Hydrochloride

First Posted Date: 2008-01-02

Last Posted Date: 2012-06-28

Lead Sponsor: University of South Florida

Target Recruit Count: 42

Registration Number: NCT00584662

Locations: 🇺🇸
USF, Tampa, Florida, United States

Pregabalin (Lyrica) for the Treatment of Essential Tremor

Phase 4

Completed

Conditions: Essential Tremor

Interventions: Drug: Placebo
Drug: Pregabalin

First Posted Date: 2008-01-02

Last Posted Date: 2012-06-18

Lead Sponsor: University of South Florida

Target Recruit Count: 29

Registration Number: NCT00584376

Locations: 🇺🇸
Emory Univ. School of Medicine, Atlanta, Georgia, United States
🇺🇸
Medical College of Georgia, Augusta, Georgia, United States
🇺🇸
Vanderbilt, Nashville, Tennessee, United States

and more 5 locations

Mindfulness-based Stress Reduction in Breast Cancer Recovery

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Behavioral: Mindfulness-Based Stress Reduction

First Posted Date: 2008-01-02

Last Posted Date: 2012-06-18

Lead Sponsor: University of South Florida

Target Recruit Count: 84

Registration Number: NCT00584142

Locations: 🇺🇸
University of South Florida, Tampa, Florida, United States

A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study

Phase 2

Terminated

Conditions: Anorexia Nervosa

First Posted Date: 2008-01-02

Last Posted Date: 2012-06-18

Lead Sponsor: University of South Florida

Target Recruit Count: 24

Registration Number: NCT00584688

Locations: 🇺🇸
University of South Floirda, Tampa, Florida, United States

Solifenacin Succinate (VESIcare) for the Treatment of Urinary Incontinence in Parkinson's Disease

Phase 4

Withdrawn

Conditions: Urinary Incontinence
Parkinson's Disease

Interventions: Drug: Solifenacin Succinate (VESIcare)
Drug: Placebo

First Posted Date: 2008-01-02

Last Posted Date: 2012-12-03

Lead Sponsor: University of South Florida

Registration Number: NCT00584090

Locations: 🇺🇸
University of South Florida, Tampa, Florida, United States

Keppra IV for the Treatment of Motor Fluctuations in Parkinson's Disease

Phase 4

Withdrawn

Conditions: Parkinson's Disease

Interventions: Drug: levetiracetam
Drug: Placebo

First Posted Date: 2008-01-02

Last Posted Date: 2021-11-16

Lead Sponsor: University of South Florida

Registration Number: NCT00584025

Locations: 🇺🇸
University of South Florida, Tampa, Florida, United States

Examination of the Role of Atrial Natriuretic Peptide Polymorphisms in Allergic Rhinitis and Asthma Severity

Terminated

Conditions: Allergic Rhinitis
Asthma

First Posted Date: 2008-01-02

Last Posted Date: 2018-10-04

Lead Sponsor: University of South Florida

Target Recruit Count: 90

Registration Number: NCT00584051

Locations: 🇺🇸
USF, Tampa, Florida, United States

MRI and Ultrasound Findings in Patients With Gout and Normal Plain Radiographs

Not Applicable

Completed

Conditions: Gout

Interventions: Other: MRI and Ultrasound

First Posted Date: 2008-01-02

Last Posted Date: 2008-06-09

Lead Sponsor: University of South Florida

Target Recruit Count: 33

Registration Number: NCT00584311

Locations: 🇺🇸
University of South Florida, Tampa, Florida, United States

Pregabalin (Lyrica) for the Treatment of Restless Legs Syndrome

Phase 4

Withdrawn

Conditions: Restless Legs Syndrome

Interventions: Drug: Pregabalin (Lyrica)
Drug: Placebo

First Posted Date: 2008-01-02

Last Posted Date: 2021-11-16

Lead Sponsor: University of South Florida

Registration Number: NCT00584246

Locations: 🇺🇸
University of South Florida, Tampa, Florida, United States

Reliability and Validity of the MINI International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)

Completed

Conditions: Major Depression
Mania
Anxiety Disorders
Psychotic Disorder
Alcohol Dependence
Drug Dependence
Eating Disorders
Suicidality
Dysthymia
ADHD

First Posted Date: 2007-12-24

Last Posted Date: 2009-02-16

Lead Sponsor: University of South Florida

Target Recruit Count: 230

Registration Number: NCT00579267

Locations: 🇺🇸
University of South Florida College of Medicine, Department of Psychiatry, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy